The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
MR contrast agents: Physical and pharmacologic basics
Open accessAbstract
Since approval of the first magnetic resonance (MR) contrast agent was granted in 1988, there has been remarkable growth in the utilization of intravenous gadolinium (Gd)‐based agents. Currently it is estimated that nearly half of all MR studies performed are contrast‐enhanced. Despite containing a toxic heavy metal, these agents have proven to be not only an effective diagnostic adjunct to non‐enhanced MRI, but also remarkably well tolerated and safe. As a result, conventional wisdom has been that MR contrast media are “biologically inert,” a notion that is clearly false. Ultimately, it is the radiologist's responsibility to understand the potential adverse effects of Gd‐based agents and the special situations in which they are likely to occur; however, the basic pharmacology of contrast agents is generally not included in medical school curricula or formally taught in residency. The purpose of this review is to discuss the mechanism of action of MR contrast agents and relevant aspects of their clinical pharmacology, including effects on the cardiovascular and renal systems, potential laboratory errors, and special situations involving women and children. We also briefly discuss the issue of nephrogenic systemic fibrosis (NSF). J. Magn. Reson. Imaging 2007;25:884–899. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grobner, T. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk062 · Cited by 1,859
Rohrer, M., Bauer, H., Mintorovitch, J., Requardt, M., & Weinmann, H.-J. (2005) · Investigative Radiology · doi:10.1097/01.rli.0000184756.66360.d3 · Cited by 1,682
Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine
Tepel, M., van der Giet, M., Schwarzfeld, C., Laufer, U., Liermann, D., & Zidek, W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007203430304 · Cited by 1,588
Marckmann, P., Skov, L., Rossen, K., Dupont, A., Damholt, M. B., Heaf, J. G., & Thomsen, H. S. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060601 · Cited by 1,400
Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent
Weinmann, H., Brasch, R., Press, W., & Wesbey, G. (1984) · American Journal of Roentgenology · doi:10.2214/ajr.142.3.619 · Cited by 1,231
Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate: A Randomized Controlled Trial
Merten, G. J., Burgess, W. P., Gray, L. V., Holleman, J. H., Roush, T. S., Kowalchuk, G. J., Bersin, R. M., Van Moore, A., Simonton III, C. A., Rittase, R. A., et al. (2004) · JAMA · doi:10.1001/jama.291.19.2328 · Cited by 1,087
Nephrogenic Systemic Fibrosis: Risk Factors and Incidence Estimation
Sadowski, E. A., Bennett, L. K., Chan, M. R., Wentland, A. L., Garrett, A. L., Garrett, R. W., & Djamali, A. (2007) · Radiology · doi:10.1148/radiol.2431062144 · Cited by 1,018
Experimental Pulse NMR: A Nuts and Bolts Approach
Fukushima, E., & Roeder, S. B. W. (2018) · CRC Press eBooks · doi:10.1201/9780429493867 · Cited by 912
ACR Guidance Document for Safe MR Practices: 2007
Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gilk, T., Gimbel, J. R., Gosbee, J., Kuhni-Kaminski, E., et al. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1616 · Cited by 787
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 604
The use of iodinated and gadolinium contrast media during pregnancy and lactation
Webb, J. A. W., Thomsen, H. S., Morcos, S. K., & Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR) (2005) · European Radiology · doi:10.1007/s00330-004-2583-y · Cited by 590
Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis
High, W. A., Ayers, R. A., Chandler, J., Zito, G., & Cowper, S. E. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.047 · Cited by 545
The relationship between thermodynamics and the toxicity of gadolinium complexes
Cacheris, W. P., Quay, S. C., & Rocklage, S. M. (1990) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(90)90055-7 · Cited by 436
Gadolinium deposition in nephrogenic fibrosing dermopathy
Boyd, A. S., Zic, J. A., & Abraham, J. L. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.10.048 · Cited by 373
Safety of magnetic resonance imaging contrast agents
Shellock, F. G., & Kanal, E. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<477::aid-jmri33>3.0.co;2-e · Cited by 321
Safety considerations in MR imaging.
Kanal, E., Shellock, F. G., & Talagala, L. (1990) · Radiology · doi:10.1148/radiology.176.3.2202008 · Cited by 302
Nephrogenic Fibrosing Dermopathy With Systemic Involvement
Ting, W. W., Stone, M. S., Madison, K. C., & Kurtz, K. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.903 · Cited by 258
MRI of Acute Abdominal and Pelvic Pain in Pregnant Patients
Birchard, K. R., Brown, M. A., Hyslop, W. B., Fırat, Z., & Semelka, R. C. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.2.01840452 · Cited by 248
Safety of gadolinium contrast angiography in patients with chronic renal insufficiency
Sam, A. D., Morasch, M. D., Collins, J., Song, G., Chen, R., & Pereles, F. S. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00315-x · Cited by 213
Leyendecker, J. R., Gorengaut, V., & Brown, J. J. (2004) · RadioGraphics · doi:10.1148/rg.245045036 · Cited by 212
Self-citationLevine, D., Barnes, P. D., & Edelman, R. R. (1999) · Radiology · doi:10.1148/radiology.211.3.r99jn20609 · Cited by 202
Physicochemical Properties of Gadoteridol and Other Magnetic Resonance Contrast Agents
Tweedle, M. F. (1992) · Investigative Radiology · doi:10.1097/00004424-199208001-00002 · Cited by 158
Normal placenta: gadolinium-enhanced dynamic MR imaging.
Marcos, H. B., Semelka, R. C., & Worawattanakul, S. (1997) · Radiology · doi:10.1148/radiology.205.2.9356634 · Cited by 145
Nyman, U., Elmståhl, B., Leander, P., Nilsson, M., Golman, K., & Almèn, T. (2002) · Radiology · doi:10.1148/radiol.2232010221 · Cited by 135
Brookes, J. A., Redpath, T. W., Gilbert, F. J., Murray, A. D., & Staff, R. T. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199902)9:2<240::aid-jmri14>3.0.co;2-# · Cited by 118
Safety of Magnetic Resonance Contrast Media
Runge, V. M. (2001) · Topics in Magnetic Resonance Imaging · doi:10.1097/00002142-200108000-00007 · Cited by 116
Osmotic Nephrosis Induced by Water-Soluble Triiodinated Contrast Media in Man
Moreau, J., Droz, D., Sabto, J., et al. (1975) · Radiology · doi:10.1148/115.2.329 · Cited by 111
Wood, M. L., & Hardy, P. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030127 · Cited by 102
Magnetic Resonance Imaging Contrast Agents Design and Physicochemical Properties of Gadodiamide
Chang, C. A. (1993) · Investigative Radiology · doi:10.1097/00004424-199303001-00003 · Cited by 89
Quantitative analysis of gadopentetate dimeglumine excreted in breast milk
Rofsky, N. M., Weinreb, J. C., & Litt, A. W. (1993) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.1880030122 · Cited by 86
Gadolinium as a CT Contrast Agent: Assessment in a Porcine Model
Gierada, D. S., & Bae, K. T. (1999) · Radiology · doi:10.1148/radiology.210.3.r99mr06829 · Cited by 84
MultiHance clinical pharmacology: Biodistribution and MR enhancement of the liver
Spinazzi, A., Lorusso, V., Pirovano, G., Taroni, P., Kirchin, M. A., & Davies, A. (1998) · Academic Radiology · doi:10.1016/s1076-6332(98)80069-x · Cited by 80
High temporal resolution dynamic contrast MRI in a high risk group for placenta accreta
Tanaka, Y., Sohda, S., Shigemitsu, S., et al. (2001) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(01)00388-5 · Cited by 77
Gadolinium-DTPA transplacental transfer and distribution in fetal tissue in rabbits.
Novak, Z., Thurmond, A. S., Ross, P. L., Jones, M. K., Thornburg, K. L. R., & Katzberg, R. W. (1993) · PubMed · Cited by 64
Gadolinium-DTPA Transplacental Transfer and Distribution in Fetal Tissue in Rabbits
Novak, Z., Thurmond, A. S., Ross, P. L., Jones, M. K., Thornburg, K. L. R., & Katzberg, R. W. (1993) · Investigative Radiology · doi:10.1097/00004424-199328090-00015 · Cited by 63
Palacios-Jaraquemada, J. M., & Bruno, C. (2000) · Radiology · doi:10.1148/radiology.216.2.r00ma26610 · Cited by 58
Interference of gadodiamide injection (OMNISCAN®) on the colorimetric determination of serum calcium
Normann, P. T., Frøysa, A., & Svaland, M. G. (1995) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519509104981 · Cited by 56
Worldwide clinical safety assessment of gadoteridol injection: an update
Runge, V. M., & Parker, J. R. (1997) · European Radiology · doi:10.1007/pl00006900 · Cited by 42
Contrast Media Increase Vascular Endothelial Permeability by Inhibiting Nitric-Oxide Production
FURUTA, W., Yamauchi, A., Dohgu, S., Nakagawa, S., Sendo, T., MAKINO, K., Oishi, R., & Kataoka, Y. (2002) · Investigative Radiology · doi:10.1097/00004424-200201000-00004 · Cited by 19
Cited by
Gadodiamide-Associated Nephrogenic Systemic Fibrosis: Why Radiologists Should Be Concerned
Broome, D. R., Girguis, M. S., Baron, P. W., Cottrell, A. C., Kjellin, I., & Kirk, G. A. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.1094 · Cited by 604
Applications and potential toxicity of magnetic iron oxide nanoparticles
Liu, G., Gao, J., Ai, H., & Chen, X. (2013) · Small · doi:10.1002/smll.201201531 · Cited by 570
Gadolinium(iii) complexes as MRI contrast agents: ligand design and properties of the complexes
Hermann, P., Kotek, J., Kubíček, V., & Lukeš, I. (2008) · Dalton Transactions · doi:10.1039/b719704g · Cited by 530
Kelly, K. M., Dean, J., Comulada, W. S., & Lee, S.-J. (2010) · European Radiology · doi:10.1007/s00330-009-1588-y · Cited by 497
Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update
Ramalho, J., Semelka, R. C., Ramalho, M., Nunes, R. H., AlObaidy, M., & Castillo, M. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4615 · Cited by 453
Metadata
- Authors
- Lin, S., & Brown, J. J.
- Venue
- Journal of Magnetic Resonance Imaging
- Publisher
- Wiley
- Published
- 2007-04-24
- Volume
- 25
- Issue
- 5
- Pages
- 884-899
- ISSN
- 1053-1807 (ISSN-L)
- 1522-2586
- OpenAlex
- W2171633513
- Cited by
- 259
- References
- 39
- FWCI
- 16.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.